<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:department>Biological Chemistry</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EF1A8A69-7A78-4BFB-8EF8-5E383331FD2B"><gtr:id>EF1A8A69-7A78-4BFB-8EF8-5E383331FD2B</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Evans</gtr:surname><gtr:orcidId>0000-0002-6290-2849</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1B6DAEB7-4DAE-40CB-BF4B-9282C18B73D5"><gtr:id>1B6DAEB7-4DAE-40CB-BF4B-9282C18B73D5</gtr:id><gtr:firstName>George</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Lomonossoff</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FE024939%2F1"><gtr:id>786DB746-CDA0-42BA-9A0B-C44DD1151CD6</gtr:id><gtr:title>Cowpea mosaic virus as a pre-formed bionanotemplate for directed mineralization.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E024939/1</gtr:grantReference><gtr:abstractText>Nanotechnology is concerned with well-defined structures of dimensions in the 1 to 100 nanometre range. The prefix nano means a one-thousand-millionth part, so for instance a nanometre (nm) is one-thousand-millionth of a metre or 1/80000 of the width of a human hair. Bionanotechnology sits at the interface of the chemical, biological and physical sciences and is a true multidisciplinary area of research. One aspect of bionanotechnology is the use of biological matter as nanoscaffolds/building materials for the preparation of nanomaterials with novel chemical and/or physical properties. Spherical nanoparticles, or nanospheres, are intriguing materials that have diverse applications including drug delivery, catalysis, and as composite structural and electronic materials. They are often synthesised using sacrificial templates, such as polymer or silica spheres, which define their shape and size. Chemical approaches are successful in the sub-10 nm scale but monodispersity, i.e. particles all of the same size, is difficult to obtain in the 20-50 nm range. This is a drawback, since nanospheres in this size range have particularly attractive properties: e.g. the semi-conductors zinc sulfide, cadium sulfide, cadmium selenide and cadmium telluride have unique optical and electrical properties, and cobalt-platinum and iron-platinum alloys are especially well suited for catalytic, ultra-high density memory, and biomedical applications. In this project we will exploit the developing technology of using engineered variants of the plant virus, Cowpea mosaic virus (CPMV), as a template for the controlled and designed fabrication of a range of nanospheres of the same size. CPMV particles exhibit the characteristics of an ideal nanotemplate in terms of their size (28 nm diameter) and their regular symmetric, structure. CPMV has several additional advantages for applications in nanotechnology. The genetic, biological and physical properties are well characterized and the structure of the virus particles is known. The CPMV particles are exceptionally robust and can be isolated readily from plants, 1 kg of plant material yields about 1 gram of virus. Further, the plant viruses are non-infectious to other organisms and present no biological hazard to humans or animals. The approach will be to modify the virus surface by genetic engineering to introduce short chains of amino acids that favour specific mineralization processes. Procedures for the mineralization of the modified virus particles will then be established and optimised. A wide range of physical analytical techniques will be needed to define the properties of the new materials. Future applications of the materials produced may include biosensors, catalysts, electromagnetic storage materials, biomedicines and nanodevices.</gtr:abstractText><gtr:technicalSummary>The plant virus Cowpea mosaic virus (CPMV) has characteristics of an ideal nanoscaffold/building block. CPMV has a diameter of 28 nm, its properties are defined and structure known. Inoculation and purification is simple and yields in gram scale can be obtained from 1 kg of leaves. Functional groups on the exterior surface of the virion makes CPMV a useful nanoscaffold allowing attachment of different moieties. Furthermore, infectious cDNA clones and chimaeric virus technology can be used to modify the surface. Nanospheres/particles are intriguing materials that have diverse applications, e.g. drug delivery, catalysis, and as composite structural and electronic materials. They are often synthesised using sacrificial templates which define their shape and size. To explore whether CPMV particles can act as a nanotemplate, chimaeric virus technology will be used to generate variants into which have been engineered peptide sequences that promote mineralization. In this instance, chimaeras will be generated that favour mineralization of silica, FePt and CoPt alloys, and zinc sulfide. Reaction of these with precursors of the inorganic deposits will generate unique nanospheres/particles. The conditions for mineralization will be optimised and the properties of the new materials will be examined by a range of physical analytical techniques. Future applications of the materials produced, after further research and development, may include biosensors, catalysts, electromagnetic storage materials, biomedicines and nanodevices.</gtr:technicalSummary><gtr:fund><gtr:end>2008-11-12</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-11-13</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>96821</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DDDCF22B-F1E2-4DBC-B1B7-A4B6F22299FA"><gtr:id>DDDCF22B-F1E2-4DBC-B1B7-A4B6F22299FA</gtr:id><gtr:title>Chemically-coupled-peptide-promoted virus nanoparticle templated mineralization.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f974df892e4f372528e22b9f657a562"><gtr:id>6f974df892e4f372528e22b9f657a562</gtr:id><gtr:otherNames>Aljabali AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C6AB5CEA-3377-4494-8CCE-BD64E9CB4BB4"><gtr:id>C6AB5CEA-3377-4494-8CCE-BD64E9CB4BB4</gtr:id><gtr:title>Environmentally benign synthesis of virus-templated, monodisperse, iron-platinum nanoparticles.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/15e1bbfbc73e0a4e9400e50f2cba4852"><gtr:id>15e1bbfbc73e0a4e9400e50f2cba4852</gtr:id><gtr:otherNames>Shah SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/885AC921-97F5-43A3-B6BA-7F0FEE6CF2F0"><gtr:id>885AC921-97F5-43A3-B6BA-7F0FEE6CF2F0</gtr:id><gtr:title>Exploitation of plant and archaeal viruses in bionanotechnology.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/60c25354221644f08521b1202fd32665"><gtr:id>60c25354221644f08521b1202fd32665</gtr:id><gtr:otherNames>Evans DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C34CE202-F2C5-40B0-8A2B-DF7C57F55A1B"><gtr:id>C34CE202-F2C5-40B0-8A2B-DF7C57F55A1B</gtr:id><gtr:title>Virus-templated silica nanoparticles.</gtr:title><gtr:parentPublicationTitle>Small (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f29df507acce1a98bab415d213f2b90f"><gtr:id>f29df507acce1a98bab415d213f2b90f</gtr:id><gtr:otherNames>Steinmetz NF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1613-6810</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E024939/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>